Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack.

Stroke Clinical Trial

Official title:

Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack. A Randomised Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00228098
• Other study ID #: VF 20040136
• Status: Recruiting
• Phase: N/A
• First received: September 26, 2005
• Last updated: September 27, 2005
• Start date: February 2005
• Est. completion date: February 2007

Study information

• Verified date: September 2005
• Source: Odense University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: The Regional Committee on Biomedical Research Ethics
• Study type: Interventional

Clinical Trial Summary

Patients with stroke or transient ischemic attach should receive advise on smoking cessation. It is however unknown if an intensive smoking cessation program is better than ordinary advise on smoking cessation during hospitalisation for stroke or transient ischemic attack.

The aim of the study was to assess if an intensive smoking cessation program made more patients stop smoking after stroke or transient ischemic attack.

Description:

Patients with stroke or transient ischemic attach should receive advise on smoking cessation. It is however unknown if an intensive smoking cessation program is better than ordinary advise on smoking cessation during hospitalisation for stroke or transient ischemic attack.

The aim of the study was to assess if an intensive smoking cessation program made more patients stop smoking after stroke or transient ischemic attack.

Patients with stroke or transient ischemic attack are admitted to the department of neurology at Odense University hospital. Patient who are smokers on admission and age < 76 years, inhabitants in Funen County and with symptoms developed before admission will be offered participation in the study unless they have severe stroke, stroke more than 3 weeks before admission, other severe disease or unable to participate.

Study participants will be randomised to either usual short advise on smoking cessation or an intensive smoking cessation program. All participants will be followed-up for 6 months with regard to smoking habits.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 300
• Est. completion date: February 2007
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Age < 76 years

• Inhabitant in Funen County

• Acute stroke or transient ischemic attack

• Symptoms with onset before admission

• Current smoker on admission

Exclusion Criteria:

• Severe stroke

• Current stroke onset more than 3 weeks before admission

• Other severe disease

• Unable to participate

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Ischemia
• Ischemic Attack, Transient
• Stroke
• Transient Ischemic Attack

Intervention

Behavioral:
• Smoking cessation

Locations

Country	Name	City	State
Denmark	Department of Neurology	Odense	Funen

Sponsors (4)

Lead Sponsor	Collaborator
Odense University Hospital	Danish Heart Foundation, Funen County, Hjernesagen

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Smoking cessation rate